SURGIFLO™, the market leader in flowable gelatin hemostasis category, is backed by robust clinical data demonstrating efficacy, safety, and efficiency.1-3A In a double-blind study, 95% of surgeons preferred SURGIFLO™ over FLOSEAL + RECOTHROM for its ability to stay in place, reach difficult-to-access anatomy, flow predictability, maintain paste consistency, not break apart and be expressed easily.4B With the same trusted efficacy, SURGIFLO™ Hemostatic Matrix Kit with Thrombin is now faster, simplier, and more consistent to prepare.5C
1 EACH
